L-fucose enhances anti-tumor immunity through modulation of monocyte-derived dendritic cell signaling
Although immunotherapies have emerged as standard of care for severals cancer types, their efficacy remains limited to ~30% of patients. Limited efficacy has in part been attributed to a lack of infiltrating tumor-suppressive immune cells and overabundance of immunosuppressive cell populations. To c...
Saved in:
Published in | The Journal of immunology (1950) Vol. 210; no. 1_Supplement; pp. 157 - 157.11 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
01.05.2023
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!